(1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate

C44H56N6O5 — CID 157285887

IUPAC(1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate
SMILESCC[C@H]1C[C@H]2C[C@H]3c4c(c5cc(O)ccc5n4C(=O)NC)CCN(C2)C13.CC[C@H]1C[C@H]2C[C@H]3c4c(c5cc(OC(C)=O)ccc5n4C(=O)NC)CCN(C2)C13
InChIInChI=1S/C23H29N3O3.C21H27N3O2/c1-4-15-9-14-10-19-21(15)25(12-14)8-7-17-18-11-16(29-13(2)27)5-6-20(18)26(22(17)19)23(28)24-3;1-3-13-8-12-9-17-19(13)23(11-12)7-6-15-16-10-14(25)4-5-18(16)24(20(15)17)21(26)22-2/h5-6,11,14-15,19,21H,4,7-10,12H2,1-3H3,(H,24,28);4-5,10,12-13,17,19,25H,3,6-9,11H2,1-2H3,(H,22,26)/t14-,15-,19+,21?;12-,13-,17+,19?/m00/s1
InChIKeyBAFODXHELIMBPF-ZWMVHUFISA-N
MW748.97 g/mol
LogP6.81
Rot. Bonds3

About (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate

(1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate (PubChem CID 157285887) has the molecular formula C44H56N6O5 and a molecular weight of 748.97 g/mol. Its IUPAC name is (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate.

Molecular Properties

Compound Name(1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate
PubChem CID157285887
Molecular FormulaC44H56N6O5
Molecular Weight748.97 g/mol
Exact Mass748.43
IUPAC Name(1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate
SMILESCC[C@H]1C[C@H]2C[C@H]3c4c(c5cc(O)ccc5n4C(=O)NC)CCN(C2)C13.CC[C@H]1C[C@H]2C[C@H]3c4c(c5cc(OC(C)=O)ccc5n4C(=O)NC)CCN(C2)C13
InChIInChI=1S/C23H29N3O3.C21H27N3O2/c1-4-15-9-14-10-19-21(15)25(12-14)8-7-17-18-11-16(29-13(2)27)5-6-20(18)26(22(17)19)23(28)24-3;1-3-13-8-12-9-17-19(13)23(11-12)7-6-15-16-10-14(25)4-5-18(16)24(20(15)17)21(26)22-2/h5-6,11,14-15,19,21H,4,7-10,12H2,1-3H3,(H,24,28);4-5,10,12-13,17,19,25H,3,6-9,11H2,1-2H3,(H,22,26)/t14-,15-,19+,21?;12-,13-,17+,19?/m00/s1
InChIKeyBAFODXHELIMBPF-ZWMVHUFISA-N
XLogP6.81
TPSA121.07 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds3
Heavy Atoms55
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500748.97
LogP ≤ 56.81
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phenol_ester', 'substructure': 'N/A'}

Analyze (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate?
The IUPAC name of (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate (CID 157285887) is (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate.
What is the SMILES notation for (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate?
The canonical SMILES for (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate is CC[C@H]1C[C@H]2C[C@H]3c4c(c5cc(O)ccc5n4C(=O)NC)CCN(C2)C13.CC[C@H]1C[C@H]2C[C@H]3c4c(c5cc(OC(C)=O)ccc5n4C(=O)NC)CCN(C2)C13.
What is the InChIKey of (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate?
The InChIKey is BAFODXHELIMBPF-ZWMVHUFISA-N. The full InChI is InChI=1S/C23H29N3O3.C21H27N3O2/c1-4-15-9-14-10-19-21(15)25(12-14)8-7-17-18-11-16(29-13(2)27)5-6-20(18)26(22(17)19)23(28)24-3;1-3-13-8-12-9-17-19(13)23(11-12)7-6-15-16-10-14(25)4-5-18(16)24(20(15)17)21(26)22-2/h5-6,11,14-15,19,21H,4,7-10,12H2,1-3H3,(H,24,28);4-5,10,12-13,17,19,25H,3,6-9,11H2,1-2H3,(H,22,26)/t14-,15-,19+,21?;12-,13-,17+,19?/m00/s1.
What are the key properties of (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate?
(1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate has a molecular weight of 748.97 g/mol, XLogP of 6.81, 3 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,15S,17S)-17-ethyl-7-hydroxy-N-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxamide;[(1R,15S,17S)-17-ethyl-3-(methylcarbamoyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] acetate is sourced from PubChem (CID 157285887), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).